Reflux and Cough

Otolaryngologic Clinics of North America

Volumn 43, Issue 1, 2010, Pages 97-110

  Merati, Albert L ^a,b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NONE   (United States)

Author keywords

Cough; Gastroesophageal reflux disease; Otolaryngology; Reflux

Indexed keywords

ALGINIC ACID; BACLOFEN; BETHANECHOL; BILE ACID; CAPSAICIN; CISAPRIDE; DOMPERIDONE; ERYTHROMYCIN; GAVISCON; METOCLOPRAMIDE; OMEPRAZOLE; PEPSIN A; PROKINETIC AGENT; PROTON PUMP INHIBITOR;

ACIDITY; ANTIREFLUX OPERATION; CAUSAL ATTRIBUTION; COUGHING; DISEASE ASSOCIATION; DRUG SAFETY; GASTRIC DYSMOTILITY; GASTROENTERITIS; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL REFLUX; HIP FRACTURE; HUMAN; LAPAROSCOPIC SURGERY; LOWER ESOPHAGUS SPHINCTER PRESSURE; NONHUMAN; PATHOGENESIS; PNEUMONIA; REVIEW; STOMACH ACID; STOMACH PH; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE;

ALGINATES; BEHAVIOR THERAPY; BIOCOMPATIBLE MATERIALS; COUGH; FOOD HABITS; GASTROESOPHAGEAL REFLUX; GLUCURONIC ACID; HEARTBURN; HEXURONIC ACIDS; HUMANS; LARYNX; PROTON PUMP INHIBITORS; REFLEX; SPEECH THERAPY;

EID: 77049103097     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2009.12.003     Document Type: Review

References (64)

1. Ribeiro M., De Castro Pereira C.A., Nery L.E., et al. A prospective longitudinal study of clinical characteristics, laboratory findings, diagnostic spectrum, and outcomes of specific therapy in adult patients with chronic cough in a general respiratory clinic. Int J Clin Pract 60 7 (2006) 799-805
2. Loehrl T.A., Smith T.L., Darling R.J., et al. Autonomic dysfunction, vasomotor rhinitis, and extraesophageal manifestations of gastroesophageal reflux. Otolaryngol Head Neck Surg 126 4 (2002) 382-387
3. Nebel O.T., Fornes M.F., and Castell D.O. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis 21 11 (1976) 953-956
4. Locke III G.R., Talley N.J., Fett S.L., et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112 5 (1997) 1448-1456
5. Altman K.W., Stephens R.M., Lyttle C.S., et al. Changing impact of gastroesophageal reflux in medical and otolaryngology practice. Laryngoscope 115 7 (2005) 1145-1153
6. Moayyedi P., and Cranney A. Hip fracture and proton pump inhibitor therapy: balancing the evidence for benefit and harm. Am J Gastroenterol 103 10 (2008) 2428-2431
7. Yang Y.X., Lewis J.D., Epstein S., et al. Long-term proton pump inhibitor therapy and risk of hip fracture. JAMA 296 24 (2006) 2947-2953
8. Altman K.W., and Radosevich J.A. Unexpected consequences of proton pump inhibitor use. Otolaryngol Head Neck Surg 141 5 (2009) 564-566
9. García Rodríguez L.A., Ruigómez A., and Panés J. Use of acid-suppressing drugs and the risk of bacterial gastroenteritis. Clin Gastroenterol Hepatol 5 (2007) 1418-1423
10. Gulmez S.E., Holm A., Frederiksen H., et al. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Arch Intern Med 167 (2007) 950-955
11. Fyke F.E., Code C.F., and Schlegel J.F. The gastroesophageal sphincter in healthy human beings. Gastroenterologia 86 (1956) 135-150
12. Gawrieh S., and Shaker R. Peripheral mechanisms affecting the lower esophageal sphincter tone. Gastroenterol Clin North Am 31 (2002) S21-S33
13. Mittal R.K., and Balaban D.H. The esophagogastric junction. N Engl J Med 336 (1997) 924-932
14. Dent J., Dodds W.J., Sekiguchi T., et al. Interdigestive phasic contractions of the human lower esophageal sphincter. Gastroenterology 84 (1983) 453-460
15. Altschuler S.M., Boyle J.T., Nixon T.E., et al. Simultaneous reflex inhibition of lower esophageal sphincter and crural diaphragm in cats. Am J Phys 249 (1985) G586-G591
16. Adhami T., Goldblum J.R., Richter J.E., et al. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol 99 (2004) 2098-2106
17. Sasaki C.T., Marotta J., Hundal J., et al. Bile-induced laryngitis: is there a basis in evidence?. Ann Otol Rhinol Laryngol 114 (2005) 192-197
18. Johnston N., Dettmar P.W., Bishwokarma B., et al. Activity/stability of human pepsin: implications for reflux attributed laryngeal disease. Laryngoscope 117 (2007) 1036-1039
19. Gill G.A., Johnston N., Buda A., et al. Laryngeal epithelial defenses against laryngopharyngeal reflux: investigations of E-cadherin, carbonic anhydrase isoenzyme III, and pepsin. Ann Otol Rhinol Laryngol 114 12 (2005) 913-921
20. Johnston N., Wells C.W., Blumin J.H., et al. Receptor-mediated uptake of pepsin by laryngeal epithelial cells. Ann Otol Rhinol Laryngol 116 (2007) 934-938
21. Koufman J.A. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 101 (1991) 1-78
22. Patterson N., Mainie I., Rafferty G., et al. Nonacid reflux episodes reaching the pharynx are important factors associated with cough. J Clin Gastroenterol 43 5 (2009) 414-419
23. Kuhn J., Toohill R.J., Ulualp S.O., et al. Pharyngeal acid reflux events in patients with vocal cord nodules. Laryngoscope 108 (1998) 1146-1149
24. Ylitalo R., and Ramel S. Extraesophageal reflux in patients with contact granuloma: a prospective controlled study. Ann Otol Rhinol Laryngol 111 (2002) 441-446
25. Hickson C., Simpson C.B., and Falcon R. Laryngeal pseudosulcus as a predictor of laryngopharyngeal reflux. Laryngoscope 111 10 (2001) 1742-1745
26. Belafsky P.C., Postma G.N., and Koufman J.A. The association between laryngeal pseudosulcus and laryngopharyngeal reflux. Otolaryngol Head Neck Surg 126 6 (2002) 649-652
27. el-Serag H.B., and Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology 113 3 (1997) 755-760
28. Shaker R., Dodds W.J., Ren J., et al. Esophagoglottal closure reflex: a mechanism of airway protection. Gastroenterology 102 3 (1992) 857-861
29. Lang I.M., Haworth S.T., Medda B.K., et al. Airway responses to esophageal acidification. Am J Physiol Regul Integr Comp Physiol 294 1 (2008) R211-R219
30. Javorkova N., Varechova S., Pecova R., et al. Acidification of the oesophagus acutely increases the cough sensitivity in patients with gastro-oesophageal reflux and chronic cough. Neurogastroenterol Motil 20 2 (2008) 119-124
31. Morrison M., Rammage L., and Emami A.J. The irritable larynx syndrome. J Voice 13 3 (1999) 447-455
32. Ferrari M., Benini L., Brotto E., et al. Omeprazole reduces the response to capsaicin but not to methacholine in asthmatic patients with proximal reflux. Scand J Gastroenterol 42 3 (2007) 299-307
33. Ziora D., Jarosz W., Dzielicki J., et al. Citric acid cough threshold in patients with gastroesophageal reflux disease rises after laparoscopic fundoplication. Chest 128 4 (2005) 2458-2464
34. Reavis K.M., Morris C.D., Gopal D.V., et al. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms. Ann Surg 239 6 (2004) 849-856 [discussion: 856-8]
35. Sato K., Umeno H., Chitose S., et al. Patterns of laryngopharyngeal and gastroesophageal reflux. J Laryngol Otol 123 Suppl 31 (2009) 42-47
36. Stein D.J., El-Serag H.B., Kuczynski J., et al. The association of body mass index with Barrett's oesophagus. Aliment Pharmacol Ther 22 10 (2005) 1005-1010
37. Smith K.J., O'Brien S.M., Smithers B.M., et al. Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. CancerEpidemiol Biomarkers Prev 14 (2005) 2481-2486
38. Halum S.L., Postma G.N., Johnston C., et al. Patients with isolated laryngopharyngeal reflux are not obese. Laryngoscope 115 6 (2005) 1042-1045
39. Everett C.F., and Morice A.H. Clinical history in gastroesophageal cough. Respir Med 101 2 (2007) 345-348
40. Belafsky P.C., Postma G.N., and Koufman J.A. Validity and reliability of the reflux symptom index (RSI). J Voice 16 2 (2002) 274-277
41. Hanson D.G., Jiang J., and Chi W. Quantitative color analysis of laryngeal erythema in chronic posterior laryngitis. J Voice 12 1 (1998) 78-83
42. Park W., Hicks D.M., Khandwala F., et al. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton pump inhibitor therapy and pretherapy predictors of response. Laryngoscope 115 7 (2005) 1230-1238
43. Hicks D.M., Ours T.M., Abelson T.I., et al. The prevalence of hypopharynx findings associated with gastroesophageal reflux in normal volunteers. J Voice 16 4 (2002) 564-579
44. Sifrim D., Dupont L., Blondeau K., et al. Weakly acidic reflux in patients with chronic unexplained cough during 24 hour pressure, pH, and impedance monitoring. Gut 54 4 (2005) 449-454
45. Agrawal A., Roberts J., Sharma N., et al. Symptoms with acid and nonacid reflux may be produced by different mechanisms. Dis Esophagus 22 5 (2009) 467-470
46. Hanson D.G., Kamel P.L., and Kahrilas P.J. Outcomes of antireflux therapy for the treatment of chronic laryngitis. Ann Otol Rhinol Laryngol 104 7 (1995) 550-555
47. Chheda N.N., and Postma G.N. Patient compliance with proton pump inhibitor therapy in an otolaryngology practice. Ann Otol Rhinol Laryngol 117 9 (2008) 670-672
48. Murry T., Tabaee A., and Aviv J.E. Respiratory retraining of refractory cough and laryngopharyngeal reflux in patients with paradoxical vocal fold movement disorder. Laryngoscope 114 8 (2004) 1341-1345
49. Murry T., Tabaee A., Owczarzak V., et al. Respiratory retraining therapy and management of laryngopharyngeal reflux in the treatment of patients with cough and paradoxical vocal fold movement disorder. Ann Otol Rhinol Laryngol 115 10 (2006) 754-758
50. Hersh M.J., Sayuk G.S., and Gyawali C.P. Long-term therapeutic outcome of patients undergoing ambulatory ph monitoring for chronic unexplained cough. J Clin Gastroenterol (2009)
51. Chang A.B., Lasserson T.J., Kiljander T.O., et al. Systematic review and meta-analysis of randomised controlled trials of gastro-oesophageal reflux interventions for chronic cough associated with gastro-oesophageal reflux. BMJ 332 7532 (2006) 11-17
52. McGlashan J.A., Johnstone L.M., Sykes J., et al. The value of a liquid alginate suspension (Gaviscon Advance) in the management of laryngopharyngeal reflux. Eur Arch Otorhinolaryngol 266 2 (2009) 243-251
53. Belafsky P.C., Postma G.N., and Koufman J.A. The validity and reliability of the reflux finding score (RFS). Laryngoscope 111 8 (2001) 1313-1317
54. Poe R.H., and Kallay M.C. Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. Chest 123 3 (2003) 679-684
55. Irwin R., Zawacki J.K., Curley F.J., et al. Chronic cough as the sole presenting manifestation of gastroesophageal reflux. Am Rev Respir Dis 140 (1989) 294-300
56. Irwin R., Curley F.J., and French C.L. Chronic cough: the spectrum and frequency of causes, key components of the diagnostic evaluation, and outcome of specific therapy. Am Rev Respir Dis 141 (1990) 640-647
57. Fitzgerald J., Allen C.J., Craven M.A., et al. Chronic cough and gastroesophageal reflux. Can Med Assoc J 140 (1989) 520-524
58. Dordal M., Baltazar M.A., Roca I., et al. Nocturnal spasmodic cough in the infant: evolution after antireflux treatment. Allerg Immunol (Paris) 26 (1994) 53-58
59. DuPont C., Molkhou P., Petrovic N., et al. Treatment using motilium of gastroesophageal reflux associated with respiratory manifestations in children. Ann Pediatr 36 (1989) 148-150
60. v Grossi L., Spezzaferro M., Sacco L.F., et al. Effect of baclofen on oesophageal motility and transient lower oesophageal sphincter relaxations in GORD patients: a 48-h manometric study. Neurogastroenterol Motil 20 7 (2008) 760-766
61. Kaufman J.A., Houghland J.E., Quiroga E., et al. Long-term outcomes of laparoscopic antireflux surgery for gastroesophageal reflux disease (GERD)-related airway disorder. Surg Endosc 20 12 (2006) 1824-1830
62. Ranson M.E., Danielson A., Maxwell J.G., et al. Prospective study of laparoscopic nissen fundoplication in a community hospital and its effect on typical, atypical, and nonspecific gastrointestinal symptoms. JSLS 11 1 (2007) 66-71
63. Tutuian R., Mainie I., Agrawal A., et al. Nonacid reflux in patients with chronic cough on acid-suppressive therapy. Chest 130 2 (2006) 386-391
64. Irwin R.S. Chronic cough due to gastroesophageal reflux disease. Chest 129 (2006) 80S-94S